{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:47:05Z","timestamp":1793245625108,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006398","name":"Roswell Park Alliance Foundation, Roswell Park Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24 CA232979-01S5"],"award-info":[{"award-number":["U24 CA232979-01S5"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R25 CA203650"],"award-info":[{"award-number":["R25 CA203650"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recurrent ovarian cancer patients, especially those resistant to platinum, lack effective curative treatments. To address this, we conducted a phase 2 clinical trial (NCT02853318) combining pembrolizumab with bevacizumab, to increase T cell infiltration into the tumor, and oral cyclophosphamide, to reduce the number of regulatory T cells. The trial accrued 40 heavily pretreated recurrent ovarian cancer patients. The primary endpoint, progression free survival, was extended to a median of 10.2 months. The secondary endpoints demonstrated an objective response rate of 47.5%, and disease control in 30% of patients for over a year while maintaining a good quality of life. We performed comprehensive molecular, immune, microbiome, and metabolic profiling on samples of trial patients. Here, we show increased T and B cell clusters and distinct microbial patterns with amino acid and lipid metabolism are linked to exceptional clinical responses. This study suggests the immune milieu and host-microbiome can be leveraged to improve antitumor response in future immunotherapy trials.<\/jats:p>","DOI":"10.1038\/s41467-024-54565-8","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:35:20Z","timestamp":1733398520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Spencer R.","family":"Rosario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-8176","authenticated-orcid":false,"given":"Mark D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuga","family":"Chilakapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-6488","authenticated-orcid":false,"given":"Eduardo Cortes","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-0409","authenticated-orcid":false,"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ Robert","family":"McGray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-7651","authenticated-orcid":false,"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-7380","authenticated-orcid":false,"given":"Brahm H.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-9267","authenticated-orcid":false,"given":"Gyorgy","family":"Paragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-7576","authenticated-orcid":false,"given":"Jennifer A.","family":"Wargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-7375","authenticated-orcid":false,"given":"Emese","family":"Zsiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"54565_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clinicians 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clinicians"},{"key":"54565_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"54565_CR3","unstructured":"Armstrong, D. K. et al. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 19, 191\u2013226 (2021)."},{"key":"54565_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang, L. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med 348, 203\u2013213 (2003).","journal-title":"N. Engl. J. Med"},{"key":"54565_CR5","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato, E. et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl Acad. Sci. USA 102, 18538\u201318543 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54565_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jamaoncol.2019.3343","volume":"5","author":"JF Liu","year":"2019","unstructured":"Liu, J. F. et al. Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial. JAMA Oncol. 5, 1731\u20131738 (2019).","journal-title":"JAMA Oncol."},{"key":"54565_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ygyno.2018.11.017","volume":"152","author":"A Varga","year":"2019","unstructured":"Varga, A. et al. Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028. Gynecol. Oncol. 152, 243\u2013250 (2019).","journal-title":"Gynecol. Oncol."},{"key":"54565_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nm.3541","volume":"20","author":"GT Motz","year":"2014","unstructured":"Motz, G. T. et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat. Med. 20, 607\u2013615 (2014).","journal-title":"Nat. Med."},{"key":"54565_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","volume":"591","author":"S Biswas","year":"2021","unstructured":"Biswas, S. et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591, 464\u2013470 (2021).","journal-title":"Nature"},{"key":"54565_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"54565_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2019.01.015","volume":"447","author":"W Li","year":"2019","unstructured":"Li, W., Deng, Y., Chu, Q. & Zhang, P. Gut microbiome and cancer immunotherapy. Cancer Lett. 447, 41\u201347 (2019).","journal-title":"Cancer Lett."},{"key":"54565_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cell.2022.01.008","volume":"185","author":"G Morad","year":"2022","unstructured":"Morad, G., Helmink, B. A., Sharma, P. & Wargo, J. A. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 185, 576 (2022).","journal-title":"Cell"},{"key":"54565_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.canlet.2018.01.050","volume":"419","author":"J Wu","year":"2018","unstructured":"Wu, J. & Waxman, D. J. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy. Cancer Lett. 419, 210\u2013221 (2018).","journal-title":"Cancer Lett."},{"key":"54565_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jamaoncol.2020.5945","volume":"7","author":"E Zsiros","year":"2021","unstructured":"Zsiros, E. et al. Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 7, 78\u201385 (2021).","journal-title":"JAMA Oncol."},{"key":"54565_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"Armstrong, D. K. et al. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl Compr. Canc Netw. 19, 191\u2013226 (2021).","journal-title":"J. Natl Compr. Canc Netw."},{"key":"54565_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","volume":"5","author":"PA Konstantinopoulos","year":"2015","unstructured":"Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I. & D\u2019Andrea, A. D. Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer. Cancer Discov. 5, 1137\u20131154 (2015).","journal-title":"Cancer Discov."},{"key":"54565_CR17","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.3390\/cancers15184669","volume":"15","author":"ED Saad","year":"2023","unstructured":"Saad, E. D. et al. Trial Design for Cancer Immunotherapy: A Methodological Toolkit. Cancers 15, 4669 (2023).","journal-title":"Cancers"},{"key":"54565_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","volume":"30","author":"UA Matulonis","year":"2019","unstructured":"Matulonis, U. A. et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann. Oncol. 30, 1080\u20131087 (2019).","journal-title":"Ann. Oncol."},{"key":"54565_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bpobgyn.2016.11.004","volume":"41","author":"K Webber","year":"2017","unstructured":"Webber, K. & Friedlander, M. Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer. Best. Pr. Res Clin. Obstet. Gynaecol. 41, 126\u2013138 (2017).","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"54565_CR20","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0002","volume":"22","author":"CD Schmults","year":"2024","unstructured":"Schmults, C. D. et al. NCCN Guidelines(R) Insights: Merkel Cell Carcinoma, Version 1.2024. J. Natl Compr. Canc Netw. 22, e240002 (2024).","journal-title":"J. Natl Compr. Canc Netw."},{"key":"54565_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"54565_CR22","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","volume":"71","author":"L de Chaisemartin","year":"2011","unstructured":"de Chaisemartin, L. et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 71, 6391\u20136399 (2011).","journal-title":"Cancer Res"},{"key":"54565_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"54565_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"54565_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman, N. et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat. Med. 28, 704\u2013712 (2022).","journal-title":"Nat. Med."},{"key":"54565_CR26","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.jmb.2019.05.030","volume":"431","author":"PHN Kao","year":"2019","unstructured":"Kao, P. H. N. & Kline, K. A. Dr. Jekyll and Mr. Hide: How Enterococcus faecalis Subverts the Host Immune Response to Cause Infection. J. Mol. Biol. 431, 2932\u20132945 (2019).","journal-title":"J. Mol. Biol."},{"key":"54565_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1126\/science.358.6363.573","volume":"358","author":"J Kaiser","year":"2017","unstructured":"Kaiser, J. Gut microbes shape response to cancer immunotherapy. Science 358, 573 (2017).","journal-title":"Science"},{"key":"54565_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2081010","volume":"11","author":"Y Tomita","year":"2022","unstructured":"Tomita, Y. et al. Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors. Oncoimmunology 11, 2081010 (2022).","journal-title":"Oncoimmunology"},{"key":"54565_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker, B. J., Wearsch, P. A., Veloo, A. C. M. & Rodriguez-Palacios, A. The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front. Immunol. 11, 906 (2020).","journal-title":"Front. Immunol."},{"key":"54565_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12275-015-5273-3","volume":"53","author":"J Kim","year":"2015","unstructured":"Kim, J. & Park, W. Indole: a signaling molecule or a mere metabolic byproduct that alters bacterial physiology at a high concentration? J. Microbiol. 53, 421\u2013428 (2015).","journal-title":"J. Microbiol."},{"key":"54565_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1096-4959(02)00097-0","volume":"133","author":"JA Raymond","year":"2002","unstructured":"Raymond, J. A. & Plopper, G. E. A bacterial TMAO transporter. Comp. Biochem Physiol. B Biochem. Mol. Biol. 133, 29\u201334 (2002).","journal-title":"Comp. Biochem Physiol. B Biochem. Mol. Biol."},{"key":"54565_CR32","first-page":"172","volume":"44","author":"J Mertin","year":"1988","unstructured":"Mertin, J. & Mertin, L. A. Modulation of in vivo immune responses following changes in the intake of essential fatty acids. Prog. Allergy 44, 172\u2013206 (1988).","journal-title":"Prog. Allergy"},{"key":"54565_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1079\/PNS19980042","volume":"57","author":"EA Miles","year":"1998","unstructured":"Miles, E. A. & Calder, P. C. Modulation of immune function by dietary fatty acids. Proc. Nutr. Soc. 57, 277\u2013292 (1998).","journal-title":"Proc. Nutr. Soc."},{"key":"54565_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00383-005-1385-x","volume":"21","author":"B Sweeney","year":"2005","unstructured":"Sweeney, B., Puri, P. & Reen, D. J. Modulation of immune cell function by polyunsaturated fatty acids. Pediatr. Surg. Int. 21, 335\u2013340 (2005).","journal-title":"Pediatr. Surg. Int."},{"key":"54565_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0899-9007(01)00576-7","volume":"17","author":"DS Kelley","year":"2001","unstructured":"Kelley, D. S. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 17, 669\u2013673 (2001).","journal-title":"Nutrition"},{"key":"54565_CR36","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/ijc.26274","volume":"130","author":"S Ganti","year":"2012","unstructured":"Ganti, S. et al. Urinary acylcarnitines are altered in human kidney cancer. Int J. Cancer 130, 2791\u20132800 (2012).","journal-title":"Int J. Cancer"},{"key":"54565_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","volume":"37","author":"J Linden","year":"2019","unstructured":"Linden, J., Koch-Nolte, F. & Dahl, G. Purine Release, Metabolism, and Signaling in the Inflammatory Response. Annu. Rev. Immunol. 37, 325\u2013347 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"54565_CR38","doi-asserted-by":"publisher","first-page":"955705","DOI":"10.3389\/fmolb.2022.955705","volume":"9","author":"X Peng","year":"2022","unstructured":"Peng, X., Zheng, T., Guo, Y. & Zhu, Y. Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer. Front. Mol. Biosci. 9, 955705 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"54565_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","volume":"70","author":"A Fiore","year":"2021","unstructured":"Fiore, A. & Murray, P. J. Tryptophan and indole metabolism in immune regulation. Curr. Opin. Immunol. 70, 7\u201314 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"54565_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/ani10020326","volume":"10","author":"AM Shah","year":"2020","unstructured":"Shah, A. M., Wang, Z. & Ma, J. Glutamine Metabolism and Its Role in Immunity, a Comprehensive Review. Animals 10, 326 (2020).","journal-title":"Animals"},{"key":"54565_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn0704","volume":"7","author":"G Mirji","year":"2022","unstructured":"Mirji, G. et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci. Immunol. 7, eabn0704 (2022).","journal-title":"Sci. Immunol."},{"key":"54565_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07232-8","volume":"9","author":"SR Rosario","year":"2018","unstructured":"Rosario, S. R. et al. Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat. Commun. 9, 5330 (2018).","journal-title":"Nat. Commun."},{"key":"54565_CR43","doi-asserted-by":"publisher","first-page":"988S","DOI":"10.1093\/jn\/130.4.988S","volume":"130","author":"JT Brosnan","year":"2000","unstructured":"Brosnan, J. T. Glutamate, at the interface between amino acid and carbohydrate metabolism. J. Nutr. 130, 988S\u2013990S (2000).","journal-title":"J. Nutr."},{"key":"54565_CR44","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A. & Wargo, J. A. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell 33, 570\u2013580 (2018).","journal-title":"Cancer Cell"},{"key":"54565_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00923-w","volume":"13","author":"E Hayase","year":"2021","unstructured":"Hayase, E. & Jenq, R. R. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer. Genome Med. 13, 107 (2021).","journal-title":"Genome Med."},{"key":"54565_CR46","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1158\/0008-5472.CAN-16-0309","volume":"76","author":"CH Johnson","year":"2016","unstructured":"Johnson, C. H., Spilker, M. E., Goetz, L., Peterson, S. N. & Siuzdak, G. Metabolite and Microbiome Interplay in Cancer Immunotherapy. Cancer Res. 76, 6146\u20136152 (2016).","journal-title":"Cancer Res."},{"key":"54565_CR47","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.21037\/apm-20-2183","volume":"9","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy. Ann. Palliat. Med. 9, 4211\u20134227 (2020).","journal-title":"Ann. Palliat. Med."},{"key":"54565_CR48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-20-3445","volume":"27","author":"Y Yi","year":"2021","unstructured":"Yi, Y. et al. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study. Clin. Cancer Res. 27, 1329\u20131340 (2021).","journal-title":"Clin. Cancer Res."},{"key":"54565_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.trecan.2021.01.010","volume":"7","author":"CB Zhou","year":"2021","unstructured":"Zhou, C. B., Zhou, Y. L. & Fang, J. Y. Gut Microbiota in Cancer Immune Response and Immunotherapy. Trends Cancer 7, 647\u2013660 (2021).","journal-title":"Trends Cancer"},{"key":"54565_CR50","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.7150\/thno.35186","volume":"9","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer. Theranostics 9, 4101\u20134114 (2019).","journal-title":"Theranostics"},{"key":"54565_CR51","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.3390\/ijms21228730","volume":"21","author":"P Vernocchi","year":"2020","unstructured":"Vernocchi, P. et al. Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 21, 8730 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"54565_CR52","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/2159-8290.CD-21-0324","volume":"11","author":"RJ Knippel","year":"2021","unstructured":"Knippel, R. J., Drewes, J. L. & Sears, C. L. The Cancer Microbiome: Recent Highlights and Knowledge Gaps. Cancer Discov. 11, 2378\u20132395 (2021).","journal-title":"Cancer Discov."},{"key":"54565_CR53","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/nu13072217","volume":"13","author":"M Szczyrek","year":"2021","unstructured":"Szczyrek, M. et al. Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review. Nutrients 13, 2217 (2021).","journal-title":"Nutrients"},{"key":"54565_CR54","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41559-018-0519-1","volume":"2","author":"S Louca","year":"2018","unstructured":"Louca, S. et al. Function and functional redundancy in microbial systems. Nat. Ecol. Evol. 2, 936\u2013943 (2018).","journal-title":"Nat. Ecol. Evol."},{"key":"54565_CR55","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fcimb.2017.00467","volume":"7","author":"S Ghosh","year":"2017","unstructured":"Ghosh, S. & O\u2019Connor, T. J. Beyond Paralogs: The Multiple Layers of Redundancy in Bacterial Pathogenesis. Front. Cell Infect. Microbiol. 7, 467 (2017).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"54565_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0592-8","volume":"10","author":"A Khoruts","year":"2018","unstructured":"Khoruts, A. Targeting the microbiome: from probiotics to fecal microbiota transplantation. Genome Med. 10, 80 (2018).","journal-title":"Genome Med."},{"key":"54565_CR57","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke, L. et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat. Cancer 2, 794\u2013802 (2021).","journal-title":"Nat. Cancer"},{"key":"54565_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24347-7","volume":"12","author":"L van Hooren","year":"2021","unstructured":"van Hooren, L. et al. Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma. Nat. Commun. 12, 4127 (2021).","journal-title":"Nat. Commun."},{"key":"54565_CR59","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41590-022-01324-w","volume":"23","author":"R Wu","year":"2022","unstructured":"Wu, R. et al. Mechanisms of CD40-dependent cDC1 licensing beyond costimulation. Nat. Immunol. 23, 1536\u20131550 (2022).","journal-title":"Nat. Immunol."},{"key":"54565_CR60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.it.2020.12.008","volume":"42","author":"L Yuan","year":"2021","unstructured":"Yuan, L., Tatineni, J., Mahoney, K. M. & Freeman, G. J. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy. Trends Immunol. 42, 209\u2013227 (2021).","journal-title":"Trends Immunol."},{"key":"54565_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12979-018-0139-2","volume":"15","author":"R Kuroda","year":"2018","unstructured":"Kuroda, R. et al. Effects of chocolate containing Leuconostoc mesenteroides strain NTM048 on immune function: a randomized, double-blind, placebo-controlled trial. Immun. Ageing 15, 29 (2018).","journal-title":"Immun. Ageing"},{"key":"54565_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06491-z","volume":"21","author":"D Lu","year":"2021","unstructured":"Lu, D. et al. Association between CD4(+) T cell counts and gut microbiota and serum cytokines levels in HIV-infected immunological non-responders. BMC Infect. Dis. 21, 742 (2021).","journal-title":"BMC Infect. Dis."},{"key":"54565_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnut.2019.00047","volume":"6","author":"A Tomova","year":"2019","unstructured":"Tomova, A. et al. The Effects of Vegetarian and Vegan Diets on Gut Microbiota. Front. Nutr. 6, 47 (2019).","journal-title":"Front. Nutr."},{"key":"54565_CR64","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1038\/s41591-022-01965-2","volume":"28","author":"RC Simpson","year":"2022","unstructured":"Simpson, R. C. et al. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome. Nat. Med. 28, 2344\u20132352 (2022).","journal-title":"Nat. Med."},{"key":"54565_CR65","doi-asserted-by":"publisher","first-page":"D498","DOI":"10.1093\/nar\/gkaa1025","volume":"49","author":"A Chang","year":"2021","unstructured":"Chang, A. et al. BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49, D498\u2013D508 (2021).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR66","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/bph.12205","volume":"169","author":"M Rouse","year":"2013","unstructured":"Rouse, M., Singh, N. P., Nagarkatti, P. S. & Nagarkatti, M. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells. Br. J. Pharm. 169, 1305\u20131321 (2013).","journal-title":"Br. J. Pharm."},{"key":"54565_CR67","doi-asserted-by":"publisher","first-page":"e129494","DOI":"10.1172\/jci.insight.129494","volume":"5","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value. JCI Insight 5, e129494 (2019).","journal-title":"JCI Insight"},{"key":"54565_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807271","volume":"13","author":"F Peyraud","year":"2022","unstructured":"Peyraud, F. et al. Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives. Front. Immunol. 13, 807271 (2022).","journal-title":"Front. Immunol."},{"key":"54565_CR69","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res 47, D766\u2013D773 (2019).","journal-title":"Nucleic Acids Res"},{"key":"54565_CR70","doi-asserted-by":"crossref","unstructured":"Langmead, B. Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics Chapter 11, Unit 11 17 (2010).","DOI":"10.1002\/0471250953.bi1107s32"},{"key":"54565_CR71","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4939-3167-5_18","volume":"1374","author":"S Ghosh","year":"2016","unstructured":"Ghosh, S. & Chan, C. K. Analysis of RNA-Seq Data Using TopHat and Cufflinks. Methods Mol. Biol. 1374, 339\u2013361 (2016).","journal-title":"Methods Mol. Biol."},{"key":"54565_CR72","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"54565_CR74","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand, J. et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat. Protoc. 14, 482\u2013517 (2019).","journal-title":"Nat. Protoc."},{"key":"54565_CR75","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"54565_CR76","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 77, e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"key":"54565_CR77","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/hep.29324","volume":"66","author":"DS Kim","year":"2017","unstructured":"Kim, D. S. et al. A liver-specific gene expression panel predicts the differentiation status of in vitro hepatocyte models. Hepatology 66, 1662\u20131674 (2017).","journal-title":"Hepatology"},{"key":"54565_CR78","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR79","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/glycob\/cwac005","volume":"32","author":"EE Irons","year":"2022","unstructured":"Irons, E. E., Cortes Gomez, E., Andersen, V. L. & Lau, J. T. Y. Bacterial colonization and TH17 immunity are shaped by intestinal sialylation in neonatal mice. Glycobiology 32, 414\u2013428 (2022).","journal-title":"Glycobiology"},{"key":"54565_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.100","volume":"70","author":"M Estaki","year":"2020","unstructured":"Estaki, M. et al. QIIME 2 Enables Comprehensive End-to-End Analysis of Diverse Microbiome Data and Comparative Studies with Publicly Available Data. Curr. Protoc. Bioinforma. 70, e100 (2020).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"54565_CR81","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR82","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/bioinformatics\/btp636","volume":"26","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26, 266\u2013267 (2010).","journal-title":"Bioinformatics"},{"key":"54565_CR83","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1101\/gr.112730.110","volume":"21","author":"BJ Haas","year":"2011","unstructured":"Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21, 494\u2013504 (2011).","journal-title":"Genome Res."},{"key":"54565_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1670-4","volume":"18","author":"X Gao","year":"2017","unstructured":"Gao, X., Lin, H., Revanna, K. & Dong, Q. A Bayesian taxonomic classification method for 16S rRNA gene sequences with improved species-level accuracy. BMC Bioinforma. 18, 247 (2017).","journal-title":"BMC Bioinforma."},{"key":"54565_CR85","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1093\/nar\/gkv784","volume":"43","author":"Y Chen","year":"2015","unstructured":"Chen, Y., Ye, W., Zhang, Y. & Xu, Y. High speed BLASTN: an accelerated MegaBLAST search tool. Nucleic Acids Res. 43, 7762\u20137768 (2015).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR86","unstructured":"McMurdie, P. J. & Holmes, S. Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac. Symp. Biocomput. 235\u2013246 (2012)."},{"key":"54565_CR87","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/bioinformatics\/btv183","volume":"31","author":"BJ Kelly","year":"2015","unstructured":"Kelly, B. J. et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics 31, 2461\u20132468 (2015).","journal-title":"Bioinformatics"},{"key":"54565_CR88","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.12688\/f1000research.8986.1","volume":"5","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J., Sankaran, K., Fukuyama, J. A., McMurdie, P. J. & Holmes, S. P. Bioconductor Workflow for Microbiome Data Analysis: from raw reads to community analyses. F1000Res. 5, 1492 (2016).","journal-title":"F1000Res."},{"key":"54565_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28034-z","volume":"13","author":"JT Nearing","year":"2022","unstructured":"Nearing, J. T. et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat. Commun. 13, 342 (2022).","journal-title":"Nat. Commun."},{"key":"54565_CR90","doi-asserted-by":"publisher","first-page":"W180","DOI":"10.1093\/nar\/gkx295","volume":"45","author":"A Dhariwal","year":"2017","unstructured":"Dhariwal, A. et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 45, W180\u2013W188 (2017).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR91","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/bioinformatics\/btv287","volume":"31","author":"KP Asshauer","year":"2015","unstructured":"Asshauer, K. P., Wemheuer, B., Daniel, R. & Meinicke, P. Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data. Bioinformatics 31, 2882\u20132884 (2015).","journal-title":"Bioinformatics"},{"key":"54565_CR92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"54565_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-8728-3_16","volume":"1849","author":"M Layeghifard","year":"2018","unstructured":"Layeghifard, M., Hwang, D. M. & Guttman, D. S. Constructing and Analyzing Microbiome Networks in R. Methods Mol. Biol. 1849, 243\u2013266 (2018).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54565-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54565-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54565-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T13:03:51Z","timestamp":1733403831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54565-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54565"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54565-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. This study was approved by the Roswell Park Institutional Review Board (IRB), and all patients provided written informed consent before initiating any study procedures. Participants did not receive financial compensation. This study followed the Consolidated Standards of Reporting Trials () reporting guideline. While all work was completed at the Roswell Park Comprehensive Cancer Center by author Shanmuga Chilakapata, this author has relocated to Northeastern University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10609"}}